ArticleAnnals of clinical and translational neurology2026

Unraveling 4-Phenylbutyrate's Therapeutic Role in SLC6A1 Disorders: Pharmacochaperoning Over HDAC Inhibition.

Melissa B DeLeeuw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.